{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:42:48Z","timestamp":1786164168587,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-026-02399-9","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:02:43Z","timestamp":1786161763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Implications of Lipoprotein(a) in MASLD"],"prefix":"10.1007","volume":"28","author":[{"given":"Nandini","family":"Avula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"2399_CR1","doi-asserted-by":"publisher","first-page":"120495","DOI":"10.1016\/j.atherosclerosis.2025.120495","volume":"409","author":"C Ratti","year":"2025","unstructured":"Ratti C, Malaguti M, Emanuele D, Bellasi A, Sanna G. Understanding MASLD \u2014 from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist. Atherosclerosis. 2025;409:120495. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120495.","journal-title":"Atherosclerosis"},{"key":"2399_CR2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, et al. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes. Clin Gastroenterol Hepatol. 2024;22:1999\u2013e20108. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.006.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2399_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","volume":"404","author":"BG Nordestgaard","year":"2024","unstructured":"Nordestgaard BG, Langsted A. Lipoprotein(a) and cardiovascular disease. Lancet. 2024;404:1255\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(24)01308-4.","journal-title":"Lancet"},{"key":"2399_CR4","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/ehq386.","journal-title":"Eur Heart J"},{"key":"2399_CR5","doi-asserted-by":"publisher","first-page":"101008","DOI":"10.1016\/j.jlr.2026.101008","volume":"67","author":"SM Marcovina","year":"2026","unstructured":"Marcovina SM, Smith S, Lin L, Tsimikas S. Analytical validation of a direct lipoprotein(a)-cholesterol assay. J Lipid Res. 2026;67:101008. https:\/\/doi.org\/10.1016\/j.jlr.2026.101008.","journal-title":"J Lipid Res"},{"key":"2399_CR6","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43:3925\u201346. https:\/\/doi.org\/10.1093\/eurheartj\/ehac361.","journal-title":"Eur Heart J"},{"key":"2399_CR7","doi-asserted-by":"publisher","unstructured":"Members WC, Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia. A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;CIR.0000000000001423. https:\/\/doi.org\/10.1161\/CIR.0000000000001423","DOI":"10.1161\/CIR.0000000000001423"},{"key":"2399_CR8","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.1038\/s41598-025-93518-z","volume":"15","author":"C Li","year":"2025","unstructured":"Li C, Li M, Wang Z. There is a linear negative correlation between lipoprotein(a) and non-alcoholic fatty liver disease. Sci Rep. 2025;15:8538. https:\/\/doi.org\/10.1038\/s41598-025-93518-z.","journal-title":"Sci Rep"},{"key":"2399_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/hep4.1830","volume":"6","author":"M Meroni","year":"2022","unstructured":"Meroni M, Longo M, Lombardi R, Paolini E, Macchi C, Corsini A, et al. Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2022;6:535\u201349. https:\/\/doi.org\/10.1002\/hep4.1830.","journal-title":"Hepatol Commun"},{"key":"2399_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2020.02.026","volume":"299","author":"K Konishi","year":"2020","unstructured":"Konishi K, Miyake T, Furukawa S, Senba H, Kanzaki S, Nakaguchi H, et al. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Atherosclerosis. 2020;299:32\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.02.026.","journal-title":"Atherosclerosis"},{"key":"2399_CR11","doi-asserted-by":"publisher","first-page":"e70208","DOI":"10.1111\/liv.70208","volume":"45","author":"T Xiao","year":"2025","unstructured":"Xiao T, Liu H, Tian N, Lian L, Miao K, Li Y, et al. Association of Plasma Lipoprotein(a) With Major Adverse Cardiovascular Events in MASLD With or Without Advanced Liver Fibrosis. Liver Int. 2025;45:e70208. https:\/\/doi.org\/10.1111\/liv.70208.","journal-title":"Liver Int"},{"key":"2399_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jacl.2023.09.003","volume":"17","author":"A Mehta","year":"2023","unstructured":"Mehta A, Lee TB, Alebna P, Grandhi GR, Dixon DL, Salloum FN, et al. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia. J Clin Lipidol. 2023;17:828\u201333. https:\/\/doi.org\/10.1016\/j.jacl.2023.09.003.","journal-title":"J Clin Lipidol"},{"key":"2399_CR13","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/jgh.16768","volume":"39","author":"A Nikoli","year":"2024","unstructured":"Nikoli A, Orfanidou M, Goulas A, Goulis DG, Polyzos SA. Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Gastro Hepatol. 2024;39:2572\u201381. https:\/\/doi.org\/10.1111\/jgh.16768.","journal-title":"J Gastro Hepatol"},{"key":"2399_CR14","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cgh.2024.10.018","volume":"23","author":"H Fan","year":"2025","unstructured":"Fan H, Kouvari M, Mingrone G, George J, Papatheodoridis G, Valenzuela-Vallejo L, et al. Lipoprotein (a) in the Full Spectrum of Metabolic Dysfunction-associated Steatotic Liver Disease: Evidence From Histologically and Genetically Characterized Cohorts. Clin Gastroenterol Hepatol. 2025;23:1356\u2013e13655. https:\/\/doi.org\/10.1016\/j.cgh.2024.10.018.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2399_CR15","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.cgh.2023.12.033","volume":"22","author":"S Pelusi","year":"2024","unstructured":"Pelusi S, Ronzoni L, Rondena J, Rosso C, Pennisi G, Dongiovanni P, et al. Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD. Clin Gastroenterol Hepatol. 2024;22:2231\u2013e22394. https:\/\/doi.org\/10.1016\/j.cgh.2023.12.033.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2399_CR16","doi-asserted-by":"publisher","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR et al. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. ATVB. 2022;42. https:\/\/doi.org\/10.1161\/ATV.0000000000000147.\u00a0\u00a0Cited 4 Mar 2026.","DOI":"10.1161\/ATV.0000000000000147"},{"key":"2399_CR17","doi-asserted-by":"publisher","unstructured":"Kronenberg F. Lipoprotein(a). In: Von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis. Cham: Springer International Publishing; 2021. pp. 201\u201332. https:\/\/doi.org\/10.1007\/164_2021_504.\u00a0Cited 23 Mar 2026.","DOI":"10.1007\/164_2021_504"},{"key":"2399_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0009-8981(94)90178-3","volume":"224","author":"C Alessandri","year":"1994","unstructured":"Alessandri C, Basili S, Maurelli M, Andreozzi P, Violi F, Cordova C. Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis. Clin Chim Acta. 1994;224:125\u20139. https:\/\/doi.org\/10.1016\/0009-8981(94)90178-3.","journal-title":"Clin Chim Acta"},{"key":"2399_CR19","doi-asserted-by":"publisher","unstructured":"Vaverkov\u00e1 H, Kar\u00e1sek D, Halenka M, Cib\u00ed\u010dkov\u00e1 L, Kub\u00ed\u010dkov\u00e1 V. Inverse Association of Lipoprotein (a) With Markers of Insulin Resistance in Dyslipidemic Subjects. Physiol Res. 2017;113\u201320. https:\/\/doi.org\/10.33549\/physiolres.933583.","DOI":"10.33549\/physiolres.933583"},{"key":"2399_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cellsig.2017.12.005","volume":"43","author":"MP Sajan","year":"2018","unstructured":"Sajan MP, Lee MC, Foufelle F, Sajan J, Cleland C, Farese RV. Coordinated regulation of hepatic FoxO1, PGC-1\u03b1 and SREBP-1c facilitates insulin action and resistance. Cell Signal. 2018;43:62\u201370. https:\/\/doi.org\/10.1016\/j.cellsig.2017.12.005.","journal-title":"Cell Signal"},{"key":"2399_CR21","doi-asserted-by":"publisher","first-page":"13972","DOI":"10.1074\/jbc.M115.638197","volume":"290","author":"JR Cook","year":"2015","unstructured":"Cook JR, Langlet F, Kido Y, Accili D. Pathogenesis of selective insulin resistance in isolated hepatocytes. J Biol Chem. 2015;290:13972\u201380. https:\/\/doi.org\/10.1074\/jbc.M115.638197.","journal-title":"J Biol Chem"},{"key":"2399_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/ATVBAHA.109.202275","volume":"30","author":"DC Chan","year":"2010","unstructured":"Chan DC, Watts GF, Gan S, Wong ATY, Ooi EMM, Barrett PHR. Nonalcoholic Fatty Liver Disease as the Transducer of Hepatic Oversecretion of Very-Low-Density Lipoprotein\u2013Apolipoprotein B-100 in Obesity. ATVB. 2010;30:1043\u201350. https:\/\/doi.org\/10.1161\/ATVBAHA.109.202275.","journal-title":"ATVB"},{"key":"2399_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-024-02389-7","volume":"23","author":"M Lejawa","year":"2024","unstructured":"Lejawa M, Go\u0142awski M, Fronczek M, Osadnik T, Paneni F, Ruscica M, et al. Causal associations between insulin and Lp(a) levels in Caucasian population: a Mendelian randomization study. Cardiovasc Diabetol. 2024;23:316. https:\/\/doi.org\/10.1186\/s12933-024-02389-7.","journal-title":"Cardiovasc Diabetol"},{"key":"2399_CR24","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1210\/jc.2016-1400","volume":"101","author":"A Vonbank","year":"2016","unstructured":"Vonbank A, Saely CH, Rein P, Zanolin D, Drexel H. Lipoprotein (a), the Metabolic Syndrome and Vascular Risk in Angiographied Coronary Patients. J Clin Endocrinol Metabolism. 2016;101:3199\u2013203. https:\/\/doi.org\/10.1210\/jc.2016-1400.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2399_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","volume":"117","author":"PR Kamstrup","year":"2008","unstructured":"Kamstrup PR, Benn M, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study. Circulation. 2008;117:176\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.715698.","journal-title":"Circulation"},{"key":"2399_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan N, H\u00e4ring H-U, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7:313\u201324. https:\/\/doi.org\/10.1016\/S2213-8587(18)30154-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2399_CR27","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson SM, Bao H, McMahon CE, Chen Y, Burr SD, Anderson AM, et al. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat Commun. 2024;15:4847. https:\/\/doi.org\/10.1038\/s41467-024-49224-x.","journal-title":"Nat Commun"},{"key":"2399_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11883-022-01016-8","volume":"24","author":"K Chemello","year":"2022","unstructured":"Chemello K, Blom DJ, Marais AD, Lambert G, Blanchard V. Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms. Curr Atheroscler Rep. 2022;24:399\u2013405. https:\/\/doi.org\/10.1007\/s11883-022-01016-8.","journal-title":"Curr Atheroscler Rep"},{"key":"2399_CR29","doi-asserted-by":"publisher","first-page":"e00504","DOI":"10.14309\/ctg.0000000000000504","volume":"13","author":"T Wu","year":"2022","unstructured":"Wu T, Ye J, Shao C, Lin Y, Wang W, Feng S, et al. The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease. Clin Transl Gastroenterol. 2022;13:e00504. https:\/\/doi.org\/10.14309\/ctg.0000000000000504.","journal-title":"Clin Transl Gastroenterol"},{"key":"2399_CR30","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","volume":"6","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Csermely A, Petracca G, Beatrice G, Corey KE, Simon TG, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:903\u201313. https:\/\/doi.org\/10.1016\/S2468-1253(21)00308-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2399_CR31","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","volume":"71","author":"TG Simon","year":"2022","unstructured":"Simon TG, Roelstraete B, Hagstr\u00f6m H, Sundstr\u00f6m J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022;71:1867\u201375. https:\/\/doi.org\/10.1136\/gutjnl-2021-325724.","journal-title":"Gut"},{"key":"2399_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2025.19615","volume":"335","author":"H Tilg","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic Dysfunction\u2013Associated Steatotic Liver Disease in Adults: A Review. JAMA. 2026;335:163. https:\/\/doi.org\/10.1001\/jama.2025.19615.","journal-title":"JAMA"},{"key":"2399_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jhep.2025.05.013","volume":"83","author":"P Ochoa-Allemant","year":"2025","unstructured":"Ochoa-Allemant P, Hubbard RA, Kaplan DE, Serper M. Cause-specific mortality in patients with steatotic liver disease in the United States. J Hepatol. 2025;83:860\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2025.05.013.","journal-title":"J Hepatol"},{"key":"2399_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.14309\/ajg.0000000000001606","volume":"117","author":"J Vieira Barbosa","year":"2022","unstructured":"Vieira Barbosa J, Milligan S, Frick A, Broestl J, Younossi Z, Afdhal N, et al. Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2022;117:453\u201361. https:\/\/doi.org\/10.14309\/ajg.0000000000001606.","journal-title":"Am J Gastroenterol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02399-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T04:02:44Z","timestamp":1786161764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02399-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02399-9","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No animal or human subjects by the authors were used in this study.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.Conflict of interest","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}